New York, New York, United States
ARCHIMED is a leading buyout firm focused exclusively on the healthcare industries. With €8.0 billion in assets, the firm serves as a strategic and financial partner to European and North American businesses in targeted segments of healthcare, including medtech, life sciences, diagnostics, healthcare IT, consumer health and pharma products and services. ARCHIMED is currently investing its second mid-cap fund, MED Platform II with €3.0 billion of total commitments and its third small-cap fund MED III, a €650 million fund. The firm is registered as an Article 9 impact investor and is a signatory of the UN Sustainable Development Goals.
Oversees ARCHIMED's investor relationships, marketing, fundraising efforts and public relations activities.
Oversee all aspects of investor relations, fundraising and marketing on a global basis. Recruited in 2010 to internalize the fundraising and investor relations effort. Successfully raised seven private equity funds and credit funds over a 10 year period.
Identified and conducted due diligence on domestic and international private equity funds including LBOs, turnaround, venture and structured equity, and raised capital from LPs globally.
Developed financial models, comps analysis and marketing materials for Merrill's Financial Sponsor clients.
Developed financial models, comps analysis and pitch books for a variety of transactions including IPOs, M&A, and private placements in technology, gaming and industrials sectors.